Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: Expert Opinions on HIV Cure Research
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Africa: Ivory Coast Makes Deal for Cheaper HIV Drugs

March 12, 2001

Three pharmaceutical companies have agreed to significantly reduce the prices of their AIDS drugs in Ivory Coast. Under the deal, the drug firms -- Bristol-Myers Squibb, Merck, and GlaxoSmithKline -- will lower the average monthly cost of treating an HIV-infected individual from $425 to between $90 and $100.


Other CDC News for March 12, 2001

South Africa May Cite Crisis to Lower Cost of AIDS Drugs

Yale Pressed to Help Cut Drug Costs in Africa

Merck & Co.

Advertisement
Behind Cipla's Offer of Cheap AIDS Drugs: Potent Mix of Motives
Africa: Ivory Coast Makes Deal for Cheaper HIV Drugs

AIDS Permeates Uganda Politics Too

Public Health Spending Up in City, Town of Burlington; Sexually Transmitted Disease Cases Jumped 50 Percent From 1999

Russians Admit to 300,000 HIV Cases
Insulin Resistance in HIV Lipodystrophy Syndrome


Adapted from:
Atlanta Journal and Constitution (www.accessatlanta.com)
03/11/01 P. 4B


  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
 
See Also
More on HIV/AIDS Treatment in Ivory Coast

Tools
 

Advertisement